Pifeltro 100 MG Oral Tablet

RxCUI
2055766
RxNorm name
Pifeltro 100 MG Oral Tablet
Display name
Pifeltro 100 MG Oral Tablet
Full name
Pifeltro 100 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PIFELTRODORAVIRINEA-S Medication Solutionsff06e5cc-f47a-4779-816b-0e5b13e88a252026-07-09Warnings, Adverse reactionsExact identifier
rxcui: 2055766
PIFELTRODORAVIRINEMerck Sharp & Dohme LLC76ce1f00-28c0-4314-bd2c-d473fe3d09702026-07-08Warnings, Adverse reactionsExact identifier
rxcui: 2055766

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
76ce1f00-28c0-4314-bd2c-d473fe3d0970Pifeltro 100 MG Oral Tablet [PSN] · doravirine 100 MG Oral Tablet [Pifeltro] [SBD] · Pifeltro 100 MG Oral Tablet [SY]320These highlights do not include all the information needed to use PIFELTRO safely and effectively. See full prescribing information for PIFELTRO. PIFELTRO ® (doravirine) tablets, for oral use Initial U.S. Approval: 201820251029
ff06e5cc-f47a-4779-816b-0e5b13e88a25Pifeltro 100 MG Oral Tablet [PSN] · doravirine 100 MG Oral Tablet [Pifeltro] [SBD] · Pifeltro 100 MG Oral Tablet [SY]33These highlights do not include all the information needed to use PIFELTRO safely and effectively. See full prescribing information for PIFELTRO. PIFELTRO ® (doravirine) tablets, for oral use Initial U.S. Approval: 201820240102